Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing

L Riva, S Yuan, X Yin, L Martin-Sancho, N Matsunaga… - Nature, 2020 - nature.com
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 2019
has triggered an ongoing global pandemic of the severe pneumonia-like disease …

Single-cell transcriptomics uncovers zonation of function in the mesenchyme during liver fibrosis

R Dobie, JR Wilson-Kanamori, BEP Henderson… - Cell reports, 2019 - cell.com
Iterative liver injury results in progressive fibrosis disrupting hepatic architecture,
regeneration potential, and liver function. Hepatic stellate cells (HSCs) are a major source of …

Hit triage and validation in phenotypic screening: considerations and strategies

F Vincent, PM Loria, AD Weston, CM Steppan… - Cell Chemical …, 2020 - cell.com
The promise of phenotypic screening resides in its track record of novel biology and first-in-
class therapies. However, challenges stemming from major differences between target …

Molecular imaging of fibroblast activity after myocardial infarction using a 68Ga-labeled fibroblast activation protein inhibitor, FAPI-04

Z Varasteh, S Mohanta, S Robu… - Journal of Nuclear …, 2019 - Soc Nuclear Med
Heart failure remains a major source of late morbidity and mortality after myocardial
infarction (MI). The temporospatial presence of activated fibroblasts in the injured …

Single-cell RNA sequencing analysis reveals a crucial role for CTHRC1 (collagen triple helix repeat containing 1) cardiac fibroblasts after myocardial infarction

A Ruiz-Villalba, JP Romero, SC Hernández… - Circulation, 2020 - Am Heart Assoc
Background: Cardiac fibroblasts (CFs) have a central role in the ventricular remodeling
process associated with different types of fibrosis. Recent studies have shown that …

The ReFRAME library as a comprehensive drug repurposing library and its application to the treatment of cryptosporidiosis

J Janes, ME Young, E Chen… - Proceedings of the …, 2018 - National Acad Sciences
The chemical diversity and known safety profiles of drugs previously tested in humans make
them a valuable set of compounds to explore potential therapeutic utility in indications …

Pathophysiology and future therapeutic perspectives for resolving fibrosis in Peyronie's disease

U Milenkovic, MM Ilg, S Cellek… - Sexual Medicine …, 2019 - academic.oup.com
Introduction Peyronie's disease (PD) is a debilitating affliction for the male population,
causing severe curvatures to the erect penis and erectile dysfunction in about 50% of men …

A large-scale drug repositioning survey for SARS-CoV-2 antivirals

L Riva, S Yuan, X Yin, L Martin-Sancho, N Matsunaga… - BioRxiv, 2020 - biorxiv.org
The emergence of novel SARS coronavirus 2 (SARS-CoV-2) in 2019 has triggered an
ongoing global pandemic of severe pneumonia-like disease designated as coronavirus …

PD-L1 mediates lung fibroblast to myofibroblast transition through Smad3 and β-catenin signaling pathways

X Guo, C Sunil, O Adeyanju, A Parker, S Huang… - Scientific Reports, 2022 - nature.com
Abstract Programmed death ligand-1 (PD-L1) is an immune checkpoint protein that has
been linked with idiopathic pulmonary fibrosis (IPF) and fibroblast to myofibroblast transition …

Mechanistic studies of a small-molecule modulator of SMN2 splicing

J Wang, PG Schultz… - Proceedings of the …, 2018 - National Acad Sciences
RG-7916 is a first-in-class drug candidate for the treatment of spinal muscular atrophy (SMA)
that functions by modulating pre-mRNA splicing of the SMN2 gene, resulting in a 2.5-fold …